Skip to main content Accessibility help
×
Home
  • Print publication year: 2012
  • Online publication date: October 2012

Chapter 25 - Genetics of stimulant dependence

Summary

Genetic analyses which are relevant to plant and animal studies, rather than human populations, have specific limitations in relation to the genetics of schizophrenia. Some reviewers of family studies of schizophrenia have drawn the conclusion that schizophrenia and bipolar disorder do not share the same genetic etiologies whereas others argue that they often do. Considerable effort has been focused on genetic linkage analysis of schizophrenia employing genetic markers in multiply affected families to identify which chromosomal regions harbor susceptibility genes. This approach must take into account the complication of heterogeneity of linkage in which a number of susceptibility genes localized to different chromosomes contribute to the development of schizophrenia. The chapter describes a selection of genes that have been implicated in susceptibility to schizophrenia by cytogenetic, linkage and/or association studies. Twin and adoption studies have shown that the family environment has no influence on the etiology of schizophrenia.

References

1. United Nations Office for Drug Control and Crime. World Drug Report 2008. Vienna: United Nations; 2008.
2. Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2007 National Survey on Drug Use and Health: National Findings. Rockville, MD: SAMHSA; 2008.
3. Nulman I, et al. Clin Invest Med 2001;24:129–137.
4. Luthar SS, et al. Int J Addict 1993;28:415–434.
5. Nurnberger JI Jr., et al. Arch Gen Psychiatry 2004;61:1246–1256.
6. Merikangas KR, et al. Arch Gen Psychiatry 1998;55:973–979.
7. Tsuang MT, et al. Am J Med Genet 1996;67:473–477.
8. Kendler KS, et al. Am J Psychiatry 2003;160:687–695.
9. Kendler KS, et al. Arch Gen Psychiatry 2003;60:929–937.
10. Kessler RC, et al. Arch Gen Psychiatry 1997;54:313–321.
11. Li MD, et al. Nat Rev Genet 2009;10:225–231.
12. Grucza RA, et al. Biol Psychiatry 2008;64:922–929.
13. Bierut LJ, et al. Am J Psychiatry 2008;165:1163–1171.
14. Gelernter J, et al. Am J Med Genet B Neuropsychiatr Genet 2005;136B:45–52.
15. Brady KT, et al. J Clin Psychiatry 1991;52:509–512.
16. Cubells JF, et al. Drug Alcohol Depend 2005;80:23–33.
17. Satel SL, et al. Am J Psychiatry 1991;148:495–498.
18. Hamer D, et al. Mol Psychiatry 2000;5:11–13.
19. Devlin B, et al. Genet Epidemiol 2001;21:273–284.
20. Lin Z, et al. Pharmacogenomics 2003;3:159–168.
21. Jacobsen LK, et al. Am J Psychiatry 2000;157:1700–1703.
22. Gelernter J, et al. Neuropsychopharmacology 1994;11:195–200.
23. Haile CN, et al. Behav Genet 2007;37:119–145.
24. Ujike H, et al. Pharmacogenomics 2003;3:242–247.
25. Hong CJ, et al. J Neural Transm 2003;110:345–351.
26. Lott DC, et al. Neuropsychopharmacology 2005;30:602–609.
27. Friedel S, et al. Mol Psychiatry 2007;12:923–933.
28. McGough JJ. Biol Psychiatry 2005;57:1367–1373.
29. O'Hara BF, et al. Hum Hered 1993;43:209–218.
30. Comings DE, et al. Drug Alcohol Depend 1994;34:175–180.
31. Persico AM, et al. Biol Psychiatry 1996;40:776–784.
32. Young RM, et al. Addict Behav 2004;29:1275–1294.
33. Noble EP, et al. Drug Alcohol Depend 1993:33:271–285.
34. Gelernter J, et al. Hum Mol Genet 2006;15:3498–3507.
35. Yang BZ, et al. Hum Mol Genet 2007;16:2844–2853.
36. Segal DM, et al. Brain Res Mol Brain Res 1997;45:335–339.
37. Staley JK, et al. J Neurosci 1996;16:6100–6106.
38. Caine SB, et al. Science 1993;260:1814–1816.
39. Rodriguez De Fonseca F, et al. Eur J Pharmacol 1995;274:47–55.
40. Comings DE, et al. Mol Psychiatry 1999;4:484–487.
41. Freimer M, et al. Addict Biol 1996;1:281–287.
42. Krebs MO, et al. Mol Psychiatry 1998;3:337–341.
43. Messas G, et al. Psychiatr Genet 2005;15:171–174.
44. Lachman HM, et al. Pharmacogenetics 1996;6:243–250.
45. Lohoff FW, et al. Neuropsychopharmacology 2008;33:3078–3084.
46. Li T, et al. Am J Med Genet B Neuropsychiatr Genet 2004;129B:120–124.
47. Suzuki A, et al. Psychiatr Genet 2006;16:133–138.
48. Oxenstierna G, et al. J Psychiatr Res 1986;20:19–29.
49. Weinshilboum RM. Hum Genet Suppl, 1978;101–112.
50. Cubells JF, et al. Mol Psychiatry 2000;5:56–63.
51. Tang YL, et al. Eur J Hum Genet 2007;15:878–883.
52. Zabetian CP, et al. Am J Hum Genet 2001;68:515–522.
53. Carroll KM, et al. Arch Gen Psychiatry 2004;61:264–272.
54. Kalayasiri R, et al. Biol Psychiatry 2007;61:1310–1313.
55. LaForge KS, et al. Eur J Pharmacol 2000;410:249–268.
56. Chen AC, et al. Am J Med Genet 2002;114:429–435.
57. Dahl JP, et al. Am J Med Genet B Neuropsychiatr Genet 2005;139B:106–108.
58. Williams TJ, et al. Addict Biol 2007;12:496–502.
59. Yuferov V, et al. Neuropsychopharmacology 2008;34:1185–1197.
60. Comings DE, et al. Mol Psychiatry 1997;2:161–168.
61. Zhang PW, et al. Mol Psychiatry 2004;9:916–931.
62. Zuo L, et al. Neuropsychopharmacology 2009;34:1504–1513.
63. Sipe JC, et al. Proc Natl Acad Sci U S A 2002;99:8394–8399.
64. Yu Y, et al. Hum Genet 2008;123:495–506.
65. Farrer LA, et al. Arch Gen Psychiatry 2009;66:267–274.
66. Uhl GR, et al. Arch Gen Psychiatry 2008;65:345–355.